Nanoscopic tau aggregates in Parkinson’s disease

2025 · doi:10.1101/2025.08.28.672923
preprint OA: closed
📄 Open PDF Full text JSON View at publisher
⚙ AI-generated deep summary by claude@2026-07, 2026-07-03 · read from full text ⓘ

The paper examined the distribution of nanoscopic tau aggregates across six brain regions in post-mortem tissue from 14 Parkinson’s disease cases and 15 controls, using a single-molecule pull-down assay (SiMPull) alongside tau immunohistochemistry (IHC). It found that in the hippocampus and amygdala, tau IHC and SiMPull measures were associated with advanced age in controls and dementia status in PD, and although tau IHC signal was negligible in the putamen, SiMPull detected a subset-specific population of high-intensity nanoscopic tau aggregates in that region, with aggregate sizes spanning ~30–1,000 nm. The authors state the aggregates’ potential link to striatal dysfunction is based on prior evidence connecting nigrostriatal tau pathology to motor deficits, which is a caveat. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Post-mortem tau pathology is frequently observed in Parkinson’s disease (PD) using immunohistochemistry (IHC) to measure large inclusions, however, small protein aggregates that precede inclusions are considered a major driver of toxicity in neurodegenerative disease. We aimed to uncover the distribution of nanoscopic aggregates across six brain regions in post-mortem tissue from 14 PD and 15 controls using the single-molecule pull-down assay (SiMPull). In the hippocampus and amygdala, tau IHC and SiMPull were associated with advanced age in controls and dementia status in PD. Despite negligible tau IHC-labelled aggregates in the putamen, we identified a unique population of high-intensity nanoscopic tau aggregates for a subset of PD cases using SiMPull, ranging from 10–1,000 epitopes per aggregate and 30–1,000 nm in length. Previous evidence linking nigrostriatal tau pathology and motor deficits indicates that the nanoscopic tau aggregates identified in this study may contribute to striatal dysfunction in PD.
Full text 1,155 characters · extracted from oa-doi-fallback · click to expand
Abstract Post-mortem tau pathology is frequently observed in Parkinson’s disease (PD) using immunohistochemistry (IHC) to measure large inclusions, however, small protein aggregates that precede inclusions are considered a major driver of toxicity in neurodegenerative disease. We aimed to uncover the distribution of nanoscopic aggregates across six brain regions in post-mortem tissue from 14 PD and 15 controls using the single-molecule pull-down assay (SiMPull). In the hippocampus and amygdala, tau IHC and SiMPull were associated with advanced age in controls and dementia status in PD. Despite negligible tau IHC-labelled aggregates in the putamen, we identified a unique population of high-intensity nanoscopic tau aggregates for a subset of PD cases using SiMPull, ranging from 10–1,000 epitopes per aggregate and 30–1,000 nm in length. Previous evidence linking nigrostriatal tau pathology and motor deficits indicates that the nanoscopic tau aggregates identified in this study may contribute to striatal dysfunction in PD. Competing Interest Statement The authors have declared no competing interest. Footnotes Updated author name Yu P. Zhang.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00